PQ203

· ProteinQure Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PQ203, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer [Phase 1]